Nov. 3 at 9:48 PM
$TELA added 7th BOD - Managing Director, Healthcare Equity Research at Canaccord Genuity is now a BOD as of 31 Oct. so no ER PR yet, but in Oct - we made 2 BOD addition or replacement. This one is interesting as he's well versed in "capital markets" in med tech space. make it what you will, but something is up here. still NO Q3 ER date/time/conf. call released. strange